PROMIS - Prostate MRI Imaging Study - Evaluation of Multi-Parametric Magnetic Resonance Imaging in the Diagnosis and Characterization of Prostate Cancer
- To determine the ability of multiparametric magnetic resonance imaging (MP-MRI) to
identify men who can safely avoid unnecessary biopsy.
- To assess the ability of the MP-MRI-based diagnostic pathway to improve the rate of
detection of clinically significant cancer as compared to transrectal ultrasound (TRUS)
- To estimate the cost-effectiveness of an MP-MRI based diagnostic pathway.
OUTLINE: This is a multicenter study.
Patients undergo multiparametric magnetic resonance imaging (MRI) (T2-weighted imaging,
diffusion-weighted MRI, and dynamic contrast-enhanced MRI) followed by template prostate
mapping and transrectal ultrasound biopsy.
Some patients may undergo blood, urine, and tissue sample collection periodically for
biomarker studies. Samples are banked for future research analysis.
Patients complete a quality-of-life questionnaire (EQ-5D) at baseline, during, and after
completion of study. An economic analysis will be performed for cost-effectiveness.
After completion of study intervention, patients are followed up periodically.
Primary Purpose: Diagnostic
Safety of multiparametric magnetic resonance imaging (MP-MRI)
Mark Emberton, MD, FRCS, MBBS
University College London Hospitals